NEU neuren pharmaceuticals limited

Ann: Proposed issue of securities - NEU, page-42

  1. 6,542 Posts.
    lightbulb Created with Sketch. 1855
    Interesting diametrically opposed positions here. Of course, rational opinion could produce arguments to support either.

    I am prepared to hold tight on two counts.

    Firstly, I believe that our SP is some distance from the high it will reach before P3 results, although in the short term, I don't discount the possibility that it will sink below $2. (However, I consider $1.70 from here a bit of a stretch - for me, that would signal an alarming lack of confidence in P3 results).

    Secondly, to hold through those results will not constitute a totally binary SP outcome, due to the cash in hand to prosecute the P2 potentials of 2591.

    However, I am on the fence as to whether or not this CR is connected with 'educated' doubt about the chance of Retts P3 success (regardless of company claims that it is totally disconnected - they could hardly say otherwise.) Therefore my confidence of a positive result has been diminished a little.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.84
Change
-0.125(0.96%)
Mkt cap ! $1.594B
Open High Low Value Volume
$12.82 $13.05 $12.53 $5.652M 441.3K

Buyers (Bids)

No. Vol. Price($)
22 1057 $12.83
 

Sellers (Offers)

Price($) Vol. No.
$12.84 504 13
View Market Depth
Last trade - 15.51pm 17/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.